No Data
Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
Shares of Pharmaceutical Companies Are Trading Lower After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.
14 Analysts Have This To Say About U.S. Bancorp